PROVIDER PROFILE · NPI 1679530372
Mary HudelsonM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
958
Unique beneficiaries
—
Total services
5,406
Distinct HCPCS
16
Medicare payment
$85K
Peer benchmark
Total Medicare services vs. 271 Allergy/ Immunology providers in TX — top quintile (cohort median 3,885).
PRESCRIBING · PART D · 2024
Total Rx claims
1,592
Beneficiaries
—
Total drug cost
$459K
Distinct drugs
27
Brand share
41.1%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter167 claims
Montelukast Sodium159 claims
Azelastine Hcl143 claims
Azithromycin125 claims
Levocetirizine Dihydrochloride115 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
76.3
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
123
By payment type
Food and Beverage$3K
Education$34
Top paying entities
Food and Beverage$3K
Education$34
REFERRAL NETWORK
Where Mary Hudelson's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Clinical Laboratory · Dallas, TX | 13 | 38 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE